A Study of Avapritinib in Pediatric Patients With Solid Tumors Dependent on KIT or PDGFRA Signaling
Blueprint Medicines Corporation
Blueprint Medicines Corporation
Reveal Pharmaceuticals Inc.
Seattle Children's Hospital
National Institutes of Health Clinical Center (CC)
Cedars-Sinai Medical Center
Thomas Jefferson University
Thomas Jefferson University
Dana-Farber Cancer Institute
St. Jude Children's Research Hospital
National Cancer Institute (NCI)
BeiGene
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Children's Oncology Group
Children's Oncology Group
National Cancer Institute (NCI)
Mayo Clinic
Radiation Therapy Oncology Group
Radiation Therapy Oncology Group
Blaze Bioscience Inc.
St. Jude Children's Research Hospital
Celgene
The Hospital for Sick Children
Memorial Sloan Kettering Cancer Center
Emory University
National Cancer Institute (NCI)
UNICANCER
Masonic Cancer Center, University of Minnesota
St. Jude Children's Research Hospital
Norwegian University of Science and Technology
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Stanford University
Children's Oncology Group
National Institutes of Health Clinical Center (CC)
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Children's Hospital Los Angeles
Radiation Therapy Oncology Group
Eisai Inc.
Canadian Cancer Trials Group
Canadian Cancer Trials Group
Mayo Clinic
Johns Hopkins All Children's Hospital
TVAX Biomedical
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group